Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
AOD-9604 is a modified fragment of human growth hormone (specifically amino acids 177-191) designed to promote fat loss without the side effects of full growth hormone therapy
Patients recovering from substance abuse or neurological conditions
It is supplied strictly as a laboratory research material for non-clinical investigations conducted under appropriate scientific protocols
The National Institute of Diabetes and Digestive and Kidney Diseases provides clinical context on how GLP-1 medications affect appetite regulation and energy balance
The drug brand is the company's most powerful citation asset
Lipotropic injections are nutrient-based formulations that typically include combinations of amino acids, vitamins, and supportive compounds
